ENZのチャート
ENZの企業情報
| symbol | ENZ |
|---|---|
| 会社名 | Enzo Biochem Inc. （ENZO BIOCHEM） |
| 分野（sector） | |
| 産業（industry） | |
| 業種 | ヘルスケア施設_サ―ビス 医療関連（Health Care） |
| 概要 | エンゾ・バイオケム（Enzo Biochem Inc.）は、製品・サービスを生産する技術力を提供することに重点を置くバイオサイエンス企業である。同社のセグメントには、Enzo Clinical Labs、Enzo Life Sciences及びEnzo Therapeuticsがある。Enzo Clinical Labsは、医師、医療センター、ほかの臨床ラボ、製薬企業に臨床サービスを提供する臨床基準研究所である。同セグメントは分子及びほかの臨床検査または検査のメニューも提供する。Enzo Life Sciencesは、臨床研究、医薬品開発、バイオサイエンス研究の顧客に製品とツールを製造、開発、販売する。Enzo Therapeuticsは、胃腸、感染、眼科及び代謝疾患の領域で複数のアプローチを開発するバイオ医薬ベンチャーである。開発パイプラインの製品には、多様な女性の健康感染症の検出、ほかの市場の病原体の同定に使用するための一連のアッセイが含まれる。 エンツォ・バイオケムは、米国の生命科学・バイオ会社。研究道具、診断法、治療法、サ―ビスに焦点を当てた秘伝や他のテストサ―ビスを医学界に提供する。事業は、臨床研究所、生命科学、治療薬に分かれる。医薬品開発と臨床研究の顧客に製品やツ―ルを開発・販売・製造のほか胃腸・感染・眼科疾患や代謝性疾患の分野でのアプロ―チを開発する。 Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform technologies that provide numerous advantages over previous standards. A global company, Enzo Biochem utilizes cross-functional teams to develop and deploy products, systems and services that meet the ever-changing and rapidly growing needs of health care today and into the future. Underpinning Enzo Biochem's products and technologies is a broad and deep intellectual property portfolio, with patent coverage across a number of key enabling technologies. |
| 本社所在地 | 527 Madison Ave New York NY 10022 USA |
| 代表者氏名 | Barry W. Weiner |
| 代表者役職名 | President Chief Financial Officer Principal Accounting Officer Treasurer Director |
| 電話番号 | +1 516-755-5500 |
| 設立年月日 | 27973 |
| 市場名 | NYSE（ニューヨーク証券取引所） |
| ipoyear | 年 |
| 従業員数 | 503人 |
| url | www.enzo.com |
| nasdaq_url | |
| adr_tso | |
| EBITDA | （百万ドル） -14.81300 |
| 終値（lastsale） | |
| 時価総額（marketcap） | |
| 時価総額 | （百万ドル） 147.39300 |
| 売上高 | （百万ドル） 90.67200 |
| 企業価値(EV) | （百万ドル） 109.87900 |
| 当期純利益 | （百万ドル） -22.07010 |
| 決算概要 | BRIEF: For the six months ended 31 January 2019 Enzo Biochem Inc. revenues decreased 23% to $40.6M. Net loss increased from $1.5M to $14.4M. Revenues reflect Clinical Labs segment decrease of 31% to $26.3M Products segment decrease of 3% to $14.3M. Higher net loss reflects Clinical Labs segment loss totaling $8M vs. income of $2.3M Products segment income decrease of 69% to $265K Other segment loss increase of 5% to $6.7M. |
ENZのテクニカル分析
ENZのニュース
Enzo Biochem: Fiscal Q2 Earnings Snapshot 2023/03/21 14:10:43 WTOP
FARMINGDALE, N.Y. (AP) — FARMINGDALE, N.Y. (AP) — Enzo Biochem Inc. (ENZ) on Monday reported a loss of $11.3 million…
Enzo Biochem GAAP EPS of -$0.23, revenue of $16.34M 2023/03/21 14:03:03 Seeking Alpha
Enzo Biochem press release (ENZ): Q2 GAAP EPS of -$0.23.Revenue of $16.34M (-52.0% Y/Y).
Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday''s Mid-Day Session 2023/03/17 16:49:21 Benzinga
Gainers Enzo Biochem, Inc. (NYSE: ENZ ) gained 86.5% to $2.22 after the company announced it will sell its clinical laboratory to Labcorp. Histogen Inc. (NASDAQ: HSTO ) climbed 60% to $1.39 after the company announced issuance of a US patent covering CTS-2090 methods of use. QualTek Services Inc. (NASDAQ: QTEK ) gained 56.4% to $0.4379. QualTek secured new money financing. AirNet Technology Inc. (NASDAQ: ANTE ) climbed 38.3% to $1.12. Maxpro Capital Acquisition Corp. (NASDAQ: JMAC ) gained 38% to $13.66. Lixiang Education Holding Co., Ltd. (NASDAQ: LXEH ) jumped 28% to $1.25. Traeger, Inc. (NYSE: COOK ) gained 24% to $3.7415 after the company announced better-than-expected Q4 results. AppTech Payments Corp. (NASDAQ: APCX ) jumped 22.8% to $1.5350. Aclarion, Inc. (NASDAQ: ACON ) gained 20% to $0.83. Berkshire Grey, Inc. (NASDAQ: BGRY ) climbed 18.3% to $1.16. Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA ) jumped 18% to $15.98 Paranovus Entertainment Technology Ltd.
CRBP, AZRE and CASA are among mid-day movers 2023/03/17 16:47:34 Seeking Alpha
Gainers: Enzo Biochem (ENZ) +85%. Traeger (COOK) +25%
Crude Oil Down 2%; Enzo Biochem Shares Spike Higher 2023/03/17 16:42:49 Benzinga
U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 300 points on Friday. The Dow traded down 1.07% to 31,899.93 while the NASDAQ fell 0.68% to 11,638.13. The S&P 500, also fell, dropping, 0.94% to 3,923.10. Check This Out: Top 5 Tech Stocks Which You''ll Regret Missing This Quarter Leading and Lagging Sectors Information technology shares fell by just 0.02% on Friday. Meanwhile, top gainers in the sector included WM Technology, Inc. (NASDAQ: MAPS ), up 14%, and Riot Platforms, Inc. (NASDAQ: RIOT ), up 11%. In trading on Thursday, financials shares dipped by 2.8%. Top Headline Industrial production came in unchanged for February, following a 0.3% increase in January. Equities Trading UP Enzo Biochem, Inc. (NYSE: ENZ ) shares shot up 86% to $2.21 after the company announced it will sell its clinical laboratory … Full story available on Benzinga.com
Enzo Biochem Inc. (NYSE:ENZ) Down Almost -36.67% In 1 Month, Long Term Looking Good As Well 2022/12/17 14:30:00 Marketing Sentinel
In last trading session, Enzo Biochem Inc. (NYSE:ENZ) saw 0.36 million shares changing hands with its beta currently measuring 0.79. Company’s recent per share price level of $1.33 trading at $0.17 or 14.66% at ring of the bell on the day assigns it a market valuation of $65.50M. That closing price of ENZ’s stock is … Enzo Biochem Inc. (NYSE:ENZ) Down Almost -36.67% In 1 Month, Long Term Looking Good As Well Read More »
Enzo Biochem, Inc. (ENZ) Q1 2023 Earnings Call Transcript 2022/12/13 14:49:05 Seeking Alpha
Enzo Biochem, Inc. (NYSE:NYSE:ENZ) Q1 2023 Earnings Conference Call December 13, 2022 08:30 A.M.
Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update 2022/12/12 22:29:00 Wallstreet:Online
- Enzo Life Sciences reports revenue of $7.1 million and 9% growth in Q1 FY 2023, excluding FX - Engagement with investment bank to provide advisory services including the evaluation of strategic alternatives for the Company is progressing well. - Continuing to make progress in market expansion of the current product portfolio, commercialization of the Company’s offerings, and optimization of
Renal Biomarkers Global Market Report 2022: Ukraine-Russia War Impact 2022/12/12 11:18:00 GlobeNewswire
Major players in the renal biomarkers market are Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter, Astute Medical Inc, Nexelis, Sphingotec GmbH, Bio-Rad Laboratories, Enzo Biochem Inc. Major players in the renal biomarkers market are Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter, Astute Medical Inc, Nexelis, Sphingotec GmbH, Bio-Rad Laboratories, Enzo Biochem Inc.
Enzo Biochem Non-GAAP EPS of -$0.17, revenue of $20.28M 2022/10/14 11:36:20 Seeking Alpha
Enzo Biochem press release (ENZ): Q4 Non-GAAP EPS of -$0.17.Revenue of $20.28M (-18.2% Y/Y).
Enzo Biochem Non-GAAP EPS of -$0.17, revenue of $20.28M 2022/10/14 11:36:20 Seeking Alpha
Enzo Biochem press release (ENZ): Q4 Non-GAAP EPS of -$0.17.Revenue of $20.28M (-18.2% Y/Y).
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday 2022/09/19 05:53:09 Benzinga
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA ) shares jumped 53% to close at $0.58 on Friday. Applied Optoelectronics, Inc. (NASDAQ: AAOI ) shares climbed 50.4% to settle at $3.76 on Friday after the company announced the sale of its Chinese manufacturing facilities to Yuhan Optoelectronic Technology for $150 million. iBio, Inc. (NYSE: IBIO ) gained 49.8% to close at $0.46. Armata Pharmaceuticals, Inc. (NYSE: ARMP ) surged 31.2% to close at $4.21. Armata Pharmaceuticals, last month, posted a Q2 loss of $0.26 per share. Axcella Health Inc. (NASDAQ: AXLA ) jumped 29.6% to close at $2.41. Axcella Health, last month, posted a Q2 loss of $0.40 per share. Anixa Biosciences, Inc. (NASDAQ: ANIX ) gained 27.5% to close at $5.71. Lannett Company, Inc. (NYSE: LCI ) gained 25.1% to close at $0.5756. Lannett Company, last month, reported Q4 FY22 sales of $74.2 million, down from $106 million a year ago Integrated Media Technology Limited (NASDAQ: IMTE ) climbed 21.5% to close at $1.75. Decisionpoint Systems, Inc. (NASDAQ: DPSI ) rose 20.8% to close at $5.93.
Enzo Biochem: Activist Pressure Could Lead To A Company Sale (NYSE:ENZ) 2022/06/27 16:01:46 Seeking Alpha
On June 9, Enzo Biochem announced a new strategic review that can finally lead to the sale of the long-mismanaged company. See more on ENZ stock here.
Enzo Biochem, Inc. (ENZ) CEO Hamid Erfanian on Q3 2022 Results - Earnings Call Transcript 2022/06/10 14:17:02 Seeking Alpha
Enzo Biochem, Inc. (NYSE:NYSE:ENZ) Q3 2022 Earnings Conference Call June 10, 2022 8:30 AM ET Company Participants Chris Calabrese - Investor Relations Hamid Erfanian - Chief Executive…